...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: New Zenith poster
6
Dec 10, 2020 04:13PM
4
Dec 11, 2020 10:43AM

That is part of my question for AGM re listing

Share
New Message
Please login to post a reply